These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25472755)

  • 1. Exploration of the value of MRCP combined with tumor marker CA19-9 in the diagnosis of pancreatic cancer.
    Ma S; Duan J; Li W; Zhang H; Hou Z
    Artif Cells Nanomed Biotechnol; 2016; 44(2):717-21. PubMed ID: 25472755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer.
    Wang WS; Liu LX; Li GP; Chen Y; Li CY; Jin DY; Wang XL
    Cancer Prev Res (Phila); 2013 Apr; 6(4):331-8. PubMed ID: 23430754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Combination of MUC5AC and CA19-9 Improves the Diagnosis of Pancreatic Cancer: A Multicenter Study.
    Kaur S; Smith LM; Patel A; Menning M; Watley DC; Malik SS; Krishn SR; Mallya K; Aithal A; Sasson AR; Johansson SL; Jain M; Singh S; Guha S; Are C; Raimondo M; Hollingsworth MA; Brand RE; Batra SK
    Am J Gastroenterol; 2017 Jan; 112(1):172-183. PubMed ID: 27845339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of pancreatic cancer using ¹⁸F-FDG PET/CT and CA19-9 with SUVmax association to clinical characteristics.
    Sun Y; Duan Q; Wang S; Zeng Y; Wu R
    J BUON; 2015; 20(2):452-9. PubMed ID: 26011335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study.
    Adamek HE; Albert J; Breer H; Weitz M; Schilling D; Riemann JF
    Lancet; 2000 Jul; 356(9225):190-3. PubMed ID: 10963196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined use of CEMIP and CA 19-9 enhances diagnostic accuracy for pancreatic cancer.
    Lee HS; Jang CY; Kim SA; Park SB; Jung DE; Kim BO; Kim HY; Chung MJ; Park JY; Bang S; Park SW; Song SY
    Sci Rep; 2018 Feb; 8(1):3383. PubMed ID: 29467409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer.
    Reitz D; Gerger A; Seidel J; Kornprat P; Samonigg H; Stotz M; Szkandera J; Pichler M
    J Clin Pathol; 2015 Jun; 68(6):427-33. PubMed ID: 25759406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA biomarkers in whole blood for detection of pancreatic cancer.
    Schultz NA; Dehlendorff C; Jensen BV; Bjerregaard JK; Nielsen KR; Bojesen SE; Calatayud D; Nielsen SE; Yilmaz M; Holländer NH; Andersen KK; Johansen JS
    JAMA; 2014 Jan 22-29; 311(4):392-404. PubMed ID: 24449318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of MRCP and indications for ERCP.
    Sakai Y; Tsuyuguchi T; Tsuchiya S; Sugiyama H; Miyakawa K; Ebara M; Saisho H; Yokosuka O
    Hepatogastroenterology; 2007 Dec; 54(80):2212-5. PubMed ID: 18265635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum APRIL, a potential tumor marker in pancreatic cancer.
    Wang F; Chen L; Ding W; Wang G; Wu Y; Wang J; Luo L; Cong H; Wang Y; Ju S; Shao J; Wang H
    Clin Chem Lab Med; 2011 Oct; 49(10):1715-9. PubMed ID: 21612541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed cut-off value of CA19-9 for detecting pancreatic cancer in patients with diabetes: a case-control study.
    Murakami M; Nagai Y; Tenjin A; Tanaka Y
    Endocr J; 2018 Jun; 65(6):639-643. PubMed ID: 29643268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The value of magnetic resonance tomography (MRT), magnetic resonance cholangiopancreatography (MRCP) and endoscopic retrograde cholangiopancreatography (ERCP) in the diagnosis of pancreatic tumors].
    Diehl SJ; Lehmann KJ; Gaa J; Meier-Willersen HJ; Wendl K; Georgi M
    Rofo; 1999 May; 170(5):463-9. PubMed ID: 10370410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can preoperative CA19-9 and CEA levels predict the resectability of patients with pancreatic adenocarcinoma?
    Kim YC; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI; Shin JH
    J Gastroenterol Hepatol; 2009 Dec; 24(12):1869-75. PubMed ID: 19686409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can MRCP replace ERCP for the diagnosis of autoimmune pancreatitis?
    Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A; Kodama M; Kamata N
    Abdom Imaging; 2009; 34(3):381-4. PubMed ID: 18437450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of enhanced magnetic resonance imaging and magnetic resonance cholangiopancreatography in the differential diagnosis of benign and malignant intraductal papillary mucinous neoplasms of the pancreas].
    Qian HF; Li FQ; Hu CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Feb; 36(1):98-101. PubMed ID: 24581137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of normalization of CA19-9 following resection for pancreatic cancer is tantamount to metastatic disease.
    Abdel-Misih SR; Hatzaras I; Schmidt C; Saab TB; Klemanski D; Muscarella P; Melvin WS; Ellison EC; Bloomston M
    Ann Surg Oncol; 2011 Apr; 18(4):1116-21. PubMed ID: 21042945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immuno-histopathological correlations in exocrine pancreatic cancer.
    Turculeanu A; Avrămescu C; Bălăşoiu M; Pleşea E; Simionescu C; Popescu CF
    Rom J Morphol Embryol; 2005; 46(2):137-44. PubMed ID: 16287000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) in the diagnosis and assessment of resectability of pancreatic tumors.
    Turowska A; Łebkowska U; Kubas B; Janica JR; Ładny RJ; Kordecki K
    Med Sci Monit; 2007 May; 13 Suppl 1():90-7. PubMed ID: 17507892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.